Breast Cancer Survival: Femara Better Than Tamoxifen
October 21, 2011 | Filed under: Health,News | Posted by:
Older women with early breast cancers have fewer recurrences and significantly longer survival times when they take the aromatase inhibitor Femara (letrozole) instead of tamoxifen, a long-term follow-up study shows.
Posted by
on October 21, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on October 21, 2011. Filed under